Literature DB >> 24401638

Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.

Daniel Fuster1, Debbie M Cheng, Emily K Quinn, Kaku A Armah, Richard Saitz, Matthew S Freiberg, Jeffrey H Samet, Judith I Tsui.   

Abstract

BACKGROUND: HIV infection leads to chronic inflammation and alterations in levels of inflammatory cytokines. The association between cytokine levels and mortality in HIV infection is not fully understood.
METHODS: We analyzed data from a cohort of HIV-infected adults with alcohol problems who were recruited in 2001-2003, and were prospectively followed until 2010 for mortality using the National Death Index. The main independent variables were inflammatory biomarkers [interleukin-6 (IL-6), IL-10, tumor necrosis factor-α, C-reactive protein, serum amyloid A, monocyte chemotactic protein-1, and cystatin-C], measured at baseline in peripheral blood and categorized as high (defined as being in the highest quartile) vs. low. A secondary analysis was conducted using inflammatory burden score, defined as the number of biomarkers in the highest quartile (0, 1, 2 or ≥ 3). Cox models were used to assess the association between both biomarker levels and inflammatory burden with mortality adjusting for potential confounders.
RESULTS: Four hundred HIV-infected patients were included (74.8% men, mean age 42 years, 50% hepatitis C virus-infected). As of 31 December 2009, 85 patients had died. In individual multivariable analyses for each biomarker, high levels of IL-6 and C-reactive protein were significantly associated with mortality [hazard ratio=2.49 (1.69-5.12), P<0.01] and [hazard ratio=1.87 (1.11-3.15), P=0.02], respectively. There was also a significant association between inflammatory burden score and mortality [hazard ratio=2.18 (1.29-3.66) for ≥ 3 vs. 0, P=0.04]. In the fully adjusted multivariable analysis, high levels of IL-6 remained independently associated with mortality [hazard ratio=2.57 (1.58-4.82), P<0.01].
CONCLUSION: High IL-6 levels and inflammatory burden score were associated with mortality in a cohort of HIV-infected adults with alcohol problems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24401638      PMCID: PMC4105144          DOI: 10.1097/QAD.0000000000000184

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  35 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Chronic hepatitis C virus infection is associated with all-cause and liver-related mortality in a cohort of HIV-infected patients with alcohol problems.

Authors:  Daniel Fuster; Debbie M Cheng; Emily K Quinn; David Nunes; Richard Saitz; Jeffrey H Samet; Judith I Tsui
Journal:  Addiction       Date:  2013-10-24       Impact factor: 6.526

3.  The reliability of the Alcohol Timeline Followback when administered by telephone and by computer.

Authors:  L C Sobell; J Brown; G I Leo; M B Sobell
Journal:  Drug Alcohol Depend       Date:  1996-09       Impact factor: 4.492

4.  Hepatitis C infection and alcohol use: A dangerous mix for the liver and antiviral immunity.

Authors:  Gyongyi Szabo; Costica Aloman; Stephen J Polyak; Steven A Weinman; Jack Wands; Sam Zakhari
Journal:  Alcohol Clin Exp Res       Date:  2006-04       Impact factor: 3.455

5.  Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts.

Authors:  J Macías; M Leal; J Delgado; J A Pineda; J Muñoz; F Relimpio; A Rubio; C Rey; E Lissen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-04       Impact factor: 3.267

6.  Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

Authors:  Katja Wolf; Dimitrios A Tsakiris; Rainer Weber; Peter Erb; Manuel Battegay
Journal:  J Infect Dis       Date:  2002-01-18       Impact factor: 5.226

7.  Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.

Authors:  Sisse R Ostrowski; Jan Gerstoft; Bente K Pedersen; Henrik Ullum
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

8.  Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.

Authors:  Jeffrey H Samet; Nicholas J Horton; Seville Meli; Kenneth A Freedberg; Anita Palepu
Journal:  Alcohol Clin Exp Res       Date:  2004-04       Impact factor: 3.455

9.  Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire.

Authors:  Jeffrey H Samet; Sharon J Phillips; Nicholas J Horton; Elizabeth T Traphagen; Kenneth A Freedberg
Journal:  AIDS Res Hum Retroviruses       Date:  2004-02       Impact factor: 2.205

10.  Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly.

Authors:  Harvey Jay Cohen; Tamara Harris; Carl F Pieper
Journal:  Am J Med       Date:  2003-02-15       Impact factor: 4.965

View more
  19 in total

1.  Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers.

Authors:  Sunitha Kodidela; Sabina Ranjit; Namita Sinha; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

2.  Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia.

Authors:  Natalia Gnatienko; Matthew S Freiberg; Elena Blokhina; Tatiana Yaroslavtseva; Carly Bridden; Debbie M Cheng; Christine E Chaisson; Dmitry Lioznov; Sally Bendiks; Glory Koerbel; Sharon M Coleman; Evgeny Krupitsky; Jeffrey H Samet
Journal:  HIV Clin Trials       Date:  2018-04-17

3.  Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.

Authors:  Martyn A French; Alessandro Cozzi-Lepri; Roberto C Arduino; Margaret Johnson; Amit C Achhra; Alan Landay
Journal:  AIDS       Date:  2015-04-24       Impact factor: 4.177

Review 4.  Role of Autophagy in HIV Pathogenesis and Drug Abuse.

Authors:  Lu Cao; Alexey Glazyrin; Santosh Kumar; Anil Kumar
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

5.  Early activation of peripheral monocytes with hallmarks of M1 and M2 monocytic cells in excessive alcohol drinkers: a pilot study.

Authors:  Crystal C Walline; Janice S Blum; Tobyn Linton; Darrin Mangiacarne; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2018-03-08       Impact factor: 3.235

Review 6.  Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.

Authors:  Daniel Fuster; Arantza Sanvisens; Ferran Bolao; Inmaculada Rivas; Jordi Tor; Robert Muga
Journal:  World J Hepatol       Date:  2016-11-08

7.  Markers of inflammation and mortality in a cohort of patients with alcohol dependence.

Authors:  Daniel Fuster; Arantza Sanvisens; Ferran Bolao; Paola Zuluaga; Inmaculada Rivas; Jordi Tor; Robert Muga
Journal:  Medicine (Baltimore)       Date:  2015-03       Impact factor: 1.889

Review 8.  Alcoholic Liver Disease: Role of Cytokines.

Authors:  Manuela G Neuman; Yaakov Maor; Radu M Nanau; Ehud Melzer; Haim Mell; Mihai Opris; Lawrence Cohen; Stephen Malnick
Journal:  Biomolecules       Date:  2015-08-28

9.  Macropinocytosis and TAK1 mediate anti-inflammatory to pro-inflammatory macrophage differentiation by HIV-1 Nef.

Authors:  M Hashimoto; H Nasser; T Chihara; S Suzu
Journal:  Cell Death Dis       Date:  2014-05-29       Impact factor: 9.685

10.  Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.

Authors:  Francesco Nicoli; Mkunde Chachage; Petra Clowes; Asli Bauer; Dickens Kowour; Barbara Ensoli; Aurelio Cafaro; Leonard Maboko; Michael Hoelscher; Riccardo Gavioli; Elmar Saathoff; Christof Geldmacher
Journal:  BMC Infect Dis       Date:  2016-07-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.